Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 3/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | TYR | P14679 | 1/20 | 0.37 |
| ▸ | TAS2R38 | P59533 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 3/20 | 0.33 |
| ▸ | CA2 | P00918 | 3/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3183385 | 0.79 | ALDH1A1 (0.48) | ALDH1A1L3MBTL1TSHRHSD17B10TP53 | |
| SCHEMBL3085435 | 0.74 | ALDH1A1 (0.43) | ALDH1A1L3MBTL1GAAKMT2A | |
| SCHEMBL20560209 | 0.72 | ALDH1A1 (0.41) | ALDH1A1L3MBTL1TSHRGAAKMT2A | |
| SCHEMBL4610474 | 0.72 | GAA (0.45) | ALDH1A1L3MBTL1TSHRHSD17B10TP53 | |
| SCHEMBL3183377 | 0.72 | ALDH1A1 (0.41) | ALDH1A1L3MBTL1TSHRGAAKMT2A | |
| SCHEMBL3070011 | 0.72 | ALDH1A1 (0.41) | ALDH1A1L3MBTL1TSHRGAAKMT2A | |
| SCHEMBL3077004 | 0.72 | ALDH1A1 (0.42) | ALDH1A1L3MBTL1TSHRGAAKMT2A | |
| SCHEMBL3068712 | 0.71 | ALDH1A1 (0.41) | ALDH1A1L3MBTL1TSHRHSD17B10GAA | |
| SCHEMBL144202 | 0.70 | KMT2A (0.50) | ALDH1A1L3MBTL1TSHRHSD17B10TP53 | |
| SCHEMBL1885075 | 0.70 | KMT2A (0.48) | ALDH1A1L3MBTL1TSHRHSD17B10TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118825418-A | Low-temperature electrolyte suitable for lithium/sodium ion battery | 哈尔滨工业大学 | 2024-10-22 | — | — | CN | claimed |
| CN-116514834-A | Chiral alpha-CF 2 H spiro [ pyrrolidine-pyrazolones]Synthesis method of class compound | 深圳市图微安创科技开发有限公司 | 2023-08-01 | — | — | CN | claimed |
| CN-113394456-A | Lithium metal battery electrolyte additive and application thereof | 厦门大学 | 2021-09-14 | — | — | CN | claimed |
| EP-1611109-A4 | NOVEL QUINAZOLINE DERIVATIVES AND METHODS OF TREATMENT RELATED TO THE USE THEREOF | TAISHO PHARMACEUTICAL CO LTD (JP) | 2009-06-24 | — | — | EP | claimed |
| JP-2006522109-A | — | — | 2006-09-28 | — | — | JP | claimed |
| EP-1611109-A1 | NOVEL QUINAZOLINE DERIVATIVES AND METHODS OF TREATMENT RELATED TO THE USE THEREOF | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2006-01-04 | — | — | EP | claimed |
| WO-2004087680-A1 | NOVEL QUINAZOLINE DERIVATIVES AND METHODS OF TREATMENT RELATED TO THE USE THEREOF | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2004-10-14 | — | — | WO | claimed |
| CN-118825418-A | Low-temperature electrolyte suitable for lithium/sodium ion battery | 哈尔滨工业大学 | 2024-10-22 | — | — | CN | disclosed |
| CN-116514834-A | Chiral alpha-CF 2 H spiro [ pyrrolidine-pyrazolones]Synthesis method of class compound | 深圳市图微安创科技开发有限公司 | 2023-08-01 | — | — | CN | disclosed |
| CN-113394456-B | Lithium metal battery electrolyte additive and application thereof | 厦门大学 | 2022-11-11 | — | — | CN | disclosed |
| US-11465135-B2 | Bifunctional chiral organocatalytic compound having excellent enantioselectivity, preparation method therefor, and method for producing non-natural gamma-amino acid from nitro compound by using same | KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION (KR) | 2022-10-11 | — | — | US | disclosed |
| CN-113394456-A | Lithium metal battery electrolyte additive and application thereof | 厦门大学 | 2021-09-14 | — | — | CN | disclosed |
| CN-112582673-A | Lithium ion battery electrolyte and lithium ion battery | 比亚迪股份有限公司 | 2021-03-30 | — | — | CN | disclosed |
| US-7696238-B2 | Substituted benzo[d]isoxazol-3-yl amine compounds as analgesics | GRUENENTHAL GMBH (DE) | 2010-04-13 | — | — | US | disclosed |
| EP-1611109-A4 | NOVEL QUINAZOLINE DERIVATIVES AND METHODS OF TREATMENT RELATED TO THE USE THEREOF | TAISHO PHARMACEUTICAL CO LTD (JP) | 2009-06-24 | — | — | EP | disclosed |
| US-20080176915-A1 | Substituted Benzo[d]isoxazol-3-yl Amine Compounds as Analgesics | GRUENENTHAL GMBH (DE) | 2008-07-24 | — | — | US | disclosed |
| US-20080004415-A1 | Non-linear optically active molecules, their synthesis, and use | OPTIMER PHOTONICS, INC. (US) | 2008-01-03 | — | — | US | disclosed |
| US-20070010671-A1 | Novel quinazoline derivatives and methods of treatment related to the use thereof | ARENA PHARMACEUTICALS, INC. | 2007-01-11 | — | — | US | disclosed |
| EP-1611109-A1 | NOVEL QUINAZOLINE DERIVATIVES AND METHODS OF TREATMENT RELATED TO THE USE THEREOF | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2006-01-04 | — | — | EP | disclosed |
| WO-2004087680-A1 | NOVEL QUINAZOLINE DERIVATIVES AND METHODS OF TREATMENT RELATED TO THE USE THEREOF | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2004-10-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11465135-B2 | Bifunctional chiral organocatalytic compound having excellent enantioselectivity, preparation method therefor, and method for producing non-natural gamma-amino acid from nitro compound by using same | NOTUM, ALDH7A1, AADAT | ALDH1A1 612/4885L3MBTL1 3229/4885TSHR 4266/4885 |
| US-20080176915-A1 | Substituted Benzo[d]isoxazol-3-yl Amine Compounds as Analgesics | KCNQ1, KCNQ2, KCNQ3 | ALDH1A1 1965/4885L3MBTL1 1736/4885TSHR 4442/4885 |
| US-20070010671-A1 | Novel quinazoline derivatives and methods of treatment related to the use thereof | MCHR1, GPR119, MCHR2 | ALDH1A1 2069/4885L3MBTL1 3309/4885TSHR 271/4885 |
| US-20080004415-A1 | Non-linear optically active molecules, their synthesis, and use | INCENP, CYBA, PAICS | ALDH1A1 378/4885L3MBTL1 2082/4885TSHR 4796/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.